Our Team

Our Team

Dr. S Chandrashekaran

Founder, Chairman


Dr. Chaitra Harsa

Managing Director


Dr. Veena Rao

CEO


Dr. Sasikumar

Head Pre-Clinical


Dr. S Chandrashekaran

Founder, Chairman

  • Dr. Chandra is the Founding Chairman of Vipragen Biosciences Pvt Ltd, a Pre-clinical drug discovery company situated in Mysore. Chandra brings several years of hands on experience in successful running and managing Biotech start-ups. He has more than 25 years of experience in the areas of recombinant technologies, Biochemistry, in vitro Biology, Drug Discovery and Biopharma. He founded Enzene Biosciences Ltd, a Biopharma R&D company and successfully exited to Alkem Laboratories Ltd in 2014. At Enzene, Chandra was instrumental in setting up Biologics (including Peptides, rDNA drugs and monoclonal antibody) platform and taken couple of biosimilar to clinical studies, several to Pre-clinical stage.

Dr. Chaitra Harsha

Managing Director

  • Dr Chaitra is a Medical Graduate (MBBS) and a PhD holder from Indian Institute of science, Bengaluru. She holds MPWE (Management Program for Women Entrepreneurs) from NSRCL for Entrepreneurship, IIM, Bengaluru. Ever since, she has been a serial entrepreneur, with 2 successfully executed ventures in healthcare and 1 venture in education. Currently she is heading the Vipragen team as Managing Director. Having acquired academic and multifaceted skill set through centers of excellence of global reputation had given an edge in the following areas of Healthcare and related areas of modern research and business development.

Dr. Sasikumar

Head Pre-Clinical

  • Dr. Sasikumar is a certified toxicologist (Diplomate of the American Board of Toxicology) with over ten years of experience, both in the biopharmaceutical industry and academic research. He obtained his Ph.D. in Toxicology on 2016 from The University of Queensland, Australia and has a Masters degree in Veterinary Pharmacology and Toxicology. He has extensive experience in the design, monitoring and interpretation of nonclinical toxicology studies. In addition, he has experience in mixture toxicology and risk assessment of chemicals. His major research experience includes nonclinical safety evaluation of new chemical entities, biosimilar, nutraceuticals, environment chemicals and mixtures.